selenium in covid_19

INTERVENTION: Intervention 1: Intervention group: Intervention group: includes 20 patients with COVID‐19 who, in addition to their usual treatments, will take 1 capsule of 200 micrograms of selenium daily for 2 weeks (14 days) after meals. Intervention 2: Intervention group: Control group: includes 20 patients with COVID‐19 who, in addition to their usual treatments, will take 1 placebo tablet (maltodextrin) daily for 2 weeks (14 days) after meals. Placebo capsules are very similar in appearance, color, smell and shape to selenium capsules. CONDITION: Covid‐19. ; U07.1 COVICOVID‐19 , virus identified U07.1 COVI PRIMARY OUTCOME: Blood leukocyte count. Timepoint: The first day and the last day of the intervention. Method of measurement: blood test. Complete number of lymphocytes. Timepoint: The first day and the last day of the intervention. Method of measurement: blood test. Complete number of neutrophils. Timepoint: The first day and the last day of the intervention. Method of measurement: blood test. Serum levels of interleukin‐6. Timepoint: The first day and the last day of the intervention. Method of measurement: Using blood sampling, the amount of serum IL6 in pc / dl by the kit. Serum levels of reactive protein‐C. Timepoint: The first day and the last day of the intervention. Method of measurement: Blood test. INCLUSION CRITERIA: Detection of COVID‐19 based on PCR tests Being 20 to 60 years old Willingness to participate in the study